Short-term fluctuations in the detection of cervical human papillomavirus DNA

Obstetrics and Gynecology

Volumn 88, Issue 2, 1996, Pages 261-268

  Wheeler, Cosette M ^a,b,c,d   Greer, Catherine E ^a,b,c,d   Becker, Thomas M ^a,b,c,d   Hunt, William C ^a,b,c,d   Anderson, Steven M ^a,b,c,d   Manos, M Michele ^a,b,c,d  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c Center for Molecular Biology   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; DOT HYBRIDIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0030221848     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/0029-7844(96)00120-2     Document Type: Article

References (25)

1. 1. Kiviat NB, Koutsky LA, Paavonen JA, Galloway DA, Critchlow CW, Beckman AM, et al. Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 1989;159:293-301.
2. 2. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, et al. Determinants of genital HPV infection in young women. J Natl Cancer Inst 1991;3:997-1000.
3. 3. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital papillomavirus infection in low-income women in Washington, D.C. Sex Trans Dis 1993;20: 279-85.
4. 4. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, et al. Determinants of genital papillomavirus infection in low-risk women in Portland, Oregon. Sex Trans Dis 1993;20:274-8.
5. 5. Wheeler CM, Parmenter CA, Hunt WC, Becker TM, Greer CE, Hildesheim A, et al. Determinants of genital papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Trans Dis 1993;20:286-9.
6. 6. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802.
7. 7. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intrapithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
8. 8. The epidemiology of human papillomavirus and cervical cancer. IARC scientific monograph no. 119. Lyon, France: IARC, 1992.
9. 9. de Villiers EM, Wagner D, Schneider A, Wesch H, Miklaw H, Wahrendorf J, et al. Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 1987;ii:703-6.
10. 10. Schneider A, Kirchhoff T, Meinhardt G, Gissman L. Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal papanicolaou smears. Obstet Gynecol 1992;79:683-8.
11. 11. Reeves WC, Arosemena JR, Garcia M, Lao SL, Cue vas M, Quiroz E, et al. Genital human papillomavirus infection in Panama City prostitutes. J Infect Dis 1989;160:599-603.
12. 12. Moscicki AB, Palefsky JM, Gonzales J, Smith G, Schoolnik GK, et al. Colposcopic and histologic findings and human papillomavirus (HPV) DNA test variability in young women positive for HPV DNA. J Infect Dis 1992;166:951-7.
13. 13. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993;82:578-85.
14. 14. Evander M, Edlund K, Gustafsson A, Jonsson M, Karlsson R, Tylander E, et al. Human papillomavirus infection is transient in young women: A population-based cohort study. J Infect Dis 1995;171:1026-30.
15. 15. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994; 169:235-40.
16. 16. Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995;87:1365-71.
17. 17. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265: 472-7.
18. 18. Bauer HC, Greer C, Manos M. Detection of genital human papillomavirus infection using PCR. In: Herrington CS, McGee JO, eds. Diagnostic molecular pathology: A practical approach. Oxford, United Kingdom: Oxford University Press, 1992:131-52.
19. 19. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
20. 20. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
21. 21. Siegsmund M, Wayss K, Eberhard A. Activation of papillomavirus genomes by chronic mechanical irritation. J Gen Virol 1991;72: 2787-9.
22. 22. McNicol PJ, Guijon FB, Paraskevas M, Heywood E, Gray MJ, Brunham RC. Effects of menstrual cycle on detection and typing of human papillomavirus in uterine cervical cells. Am J Obstet Gynecol 1990;162:1037-41.
23. 23. Fairley CK, Robinson PM, Chen S, Tabrizi SN, Garland SM. The detection of HPV DNA, the size of tampon specimens and the menstrual cycle. Genitourin Med 1994;70:171-4.
24. 24. Fairley CK, Chen S, Tabrizi S, Quinn M, Garland S. Influence of quartile of menstrual cycle on pellet volume of specimens from tampons and isolation of human papillomavirus. J Infect Dis 1992;166:1199-200.
25. 25. McNicol P, Paraskevas M, Guijon F. Variability of polymerase chain reaction-based detection of human papillomavirus DNA is associated with the composition of vaginal microbial flora. J Med Virol 1994;43:194-200.